David Liska

Cleveland Clinic

Papers

2

Total Citations

15

H-Index

2

About

David Liska is a leading colorectal surgeon whose research centers on advancing minimally invasive and robotic surgical techniques for rectal cancer and complex colorectal disease. His major contributions include pioneering the use of the single-port Da Vinci-SP robot for endoluminal surgery, as demonstrated in his landmark 2023 study on endorobotic submucosal dissection of rectal lesions—the first reported case series of its kind, which has already garnered 13 citations for its innovative approach. He has also critically examined the economic viability of robotic surgery, showing in a long-term follow-up study that cost-conscious robotic restorative proctectomy can achieve oncologic outcomes and direct hospital costs comparable to open surgery, challenging assumptions about robotic surgery’s expense. With a focus on translating cutting-edge technology into practical, patient-centered care, Liska’s work bridges surgical innovation and health economics. His research is highly cited in the colorectal surgery community, reflecting its immediate impact on clinical practice. As a surgeon-scientist, he continues to shape the future of minimally invasive colorectal oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
15
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Endorobotic submucosal dissection of rectal lesions using the single port robot <scp>DaVinci‐SP</scp>: initial experience of the first 10 cases
13 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Cleveland Clinic

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago